Zevra CFO Justin Renz files insider report

ZEVRA THERAPEUTICS, INC. filed an insider ownership report identifying Justin A. Renz as its CFO and reporting person.

Accepted by SEC EDGAR 03/19/2026 - 04:14 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

ZEVRA THERAPEUTICS, INC. filed an insider ownership report identifying Justin A. Renz as its CFO and reporting person. The data show no reported purchases, sales, acquisitions, dispositions, exercises, gifts, tax withholdings, or restructuring transactions, and no listed derivative positions or holdings in this filing.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ZVRA's Form 3 filing for Justin A. Renz show?

The Form 3 identifies Justin A. Renz as CFO and a reporting person for ZEVRA THERAPEUTICS, INC. It lists no buy, sell, acquire, or dispose transactions and shows no derivative holdings in the summarized data provided.

Does the ZVRA Form 3 for Justin A. Renz report any stock trades?

No trades are reported. The transaction summary shows zero purchases, zero sales, zero acquisitions, zero dispositions, and zero exercises, indicating no reportable trading or derivative activity for Justin A. Renz in this Form 3 data.

Are there any derivative securities reported for ZVRA CFO Justin A. Renz?

No derivative securities are listed. The derivative summary is empty and the transaction summary shows zero derivative transactions or exercises, indicating no reportable option, warrant, or other derivative positions in this specific Form 3 snapshot.

What role does Justin A. Renz hold at ZEVRA THERAPEUTICS, INC.?

Justin A. Renz is reported as an officer of ZEVRA THERAPEUTICS, INC., with the title of CFO. This officer status is explicitly stated in the Form 3 data and forms the basis for his status as a reporting person.

Does the ZVRA Form 3 indicate net buying or selling by Justin A. Renz?

The net activity is neutral. The transaction summary shows zero net buy or sell shares and a net buy-sell direction of “neutral,” reflecting the absence of any reported trading activity in this Form 3 information.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Renz Justin A

(Last) (First) (Middle)

C/O ZEVRA THERAPEUTICS, INC.

101 FEDERAL STREET

(Street)

BOSTON MASSACHUSETTS 02110

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ZEVRA THERAPEUTICS, INC. [ ZVRA ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

No securities are beneficially owned.

	/s/ Brian Keane, Attorney-in-Fact for Justin Renz	03/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)